Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Dendritic cell pattern-recognition and antigen-presentation pathways represent the integrated biological processes by which dendritic cells (DCs) detect pathogens and initiate adaptive immune responses. DCs utilize various pattern recognition receptors (PRRs), such as Toll-like receptors (TLRs) and C-type lectin receptors, to sense pathogen-associated molecular patterns (PAMPs) or damage-associated molecular patterns (DAMPs) (Janeway & Medzhitov, 2002, Annu Rev Immunol). Upon activation, DCs undergo maturation, characterized by the upregulation of co-stimulatory molecules like CD80 and CD86 and the processing of captured antigens into peptides (Banchereau & Steinman, 1998, Nature). These peptides are then loaded onto Major Histocompatibility Complex (MHC) class I and II molecules for presentation to CD8+ and CD4+ T cells, respectively (Roche & Furuta, 2015, Nat Rev Immunol). This pathway is a critical bridge between innate and adaptive immunity and is frequently targeted in immunotherapy and vaccine development to enhance anti-tumor or anti-viral responses (Mellman & Steinman, 2001, Cell). Drugs such as imiquimod and various DC-based vaccines (e.g., Sipuleucel-T) aim to modulate these pathways to stimulate robust T-cell mediated immunity (Adams, 2009, Immunotherapy).
Activation of pattern recognition receptors (PRRs) to induce dendritic cell maturation, antigen processing, and MHC-mediated presentation to T cells.
4 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Dendritic cell pattern-recognition and antigen-presentation pathways (DC PRR-AP).